Timothy L. Moore insider trades

Open-market stock purchases and sales by Timothy L. Moore, Director at Biolife Solutions Inc, from SEC Form 4 filings since Mar 15, 2016.

Track record: 0% of 2 scored buys are up 5% or more since purchase, averaging -39%.

Recent trades

DateStockTradeValue
Feb 24, 2026BLFS Biolife Solutions IncBought (not open market)—

Companies traded

  • BLFS Biolife Solutions Inc: other filings, last Feb 24, 2026
  • CERS Cerus Corp: 3 buys, last Jun 3, 2025
  • ALLO Allogene Therapeutics, Inc: 1 sale, last Feb 3, 2025
  • TIL Instil Bio, Inc: other filings, last Sep 6, 2022
  • KITE Kite Pharma, Inc: 8 sales, last Oct 3, 2017

Get free alerts when Timothy L. Moore files a new trade →